USPTO serial 79366929
TRINCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 10, 2024
- Examiner
- MAHMOUDI, MARIAM AZIZ
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TRINCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Clifford D Hyra
Clifford D Hyra Fresh IP PLC11710 Plaza America Drive Suite 2000Reston, VA 20190United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Cells for medical or clinical use; personalized autologous or allogeneic cell-based therapies in the nature of cells for medical use; biological preparations for use in cell cultures for medical applications; pharmaceutical preparations and substances for the treatment of genetic diseases in the nature of single-gene disorders, immunological diseases and cancer; pharmaceutical preparations and substances for applications in tissue engineering and regenerative medicine for cell transplantation, stem cell therapy and gene therapy; reagents for medical use; biological reagents for medical use; diagnostic reagents for medical use; reagents for use in medical genetic testing; stem cells for medical purposes; engineered medicinal cell-based products, cell lines and biomolecules, namely, genetically engineered cells for medical use; medical reagents contained in a cartridge for medical diagnostic use | ACTIVE | — |
| 009 | Scientific apparatus and instruments for cell modification, namely, transfection devices; scientific apparatus and instruments for scientific research and development, namely, transfection devices for cell modification; scientific apparatus and instruments for scientific research and development, namely, devices for transfection of cells for clinical research and medical research; Scientific apparatus and instruments for use in cell therapy, stem cell therapy, tissue engineering and regenerative medicine, namely, devices for the ablation and killing of cells; laboratory instruments for use in immunotherapy and cancer treatment, namely, transfection devices; laboratory instruments for use in tissue engineering and regenerative medicine, namely, devices for transfection, cell and tissue ablation and cell killing; laboratory instruments for the development of gene modified cell therapies, namely, transfection devices; laboratory equipment for modification of cells for research related to the treatment of diseases, namely, devices for transfection, cell ablation and cell killing; equipment for cell manipulation, namely, devices for transfection, cell ablation and cell killing | ACTIVE | — |
| 010 | Medical devices, namely, transfection devices used for cell therapy treatments; Medical devices, namely, instruments used for immunotherapy treatments and for modifying cells for the treatment of cancer and other diseases and medical conditions related to tissue engineering and regenerative medicine namely, devices for transfection, cell ablation and cell killing; apparatus for the regeneration of stem cells and tissues for medical purpose; medical apparatus and instruments for use in cell therapy, stem cell therapy, tissue engineering and regenerative medicine, namely, devices for transfection, cell ablation and cell killing; unfilled cartridges for cell transfection, cell ablation and cell killing for medical diagnostic purposes | ACTIVE | — |
| 037 | Installation, maintenance, and repair of medical apparatus and instruments; installation, maintenance and repair of laboratory apparatus and instruments; installation, maintenance, and repair of scientific apparatus and instruments for scientific research and development in the field of cell modification, cell therapies, stem cell therapy, tissue engineering and regenerative medicine; provision of information relating to the installation, maintenance, and repair of medical apparatus and instruments, laboratory apparatus and instruments, and scientific apparatus and instruments for scientific research and development in the field of cell modification, cell therapies, stem cell therapy, tissue engineering and regenerative medicine | ACTIVE | — |
| 041 | Educational services, namely, conducting classes, seminars, courses and workshops in the medical, pharmaceutical and scientific fields; educational services in the field of genetic medicine and therapies, cell therapies and gene-modified cell therapies rendered through face-to-face and web-based courses, seminars, workshops and training sessions; training services in the medical, pharmaceutical and scientific fields; Training in the use and operation of scientific apparatus for cell modification and scientific apparatus and instruments for scientific research and development; organization and conducting of workshops in the medical, pharmaceutical and scientific fields; publication of books in the medical, pharmaceutical and scientific fields; providing online non-downloadable electronic publications in the nature of books, magazines, journals, articles and manuals featuring information relating to the medical, pharmaceutical and scientific fields | ACTIVE | — |
| 042 | Scientific research and consultation services in the field of cell modification; research and development services in the field of cell therapies; biological and medical research and consultation services related thereto in the field of cell modification; product research and development in the fields of biology and medical sciences; providing laboratory research services in the field of gene expression; providing medical research information in the field of cancer and cell therapy related thereto; medical and scientific research services related to the use of human stem cells for therapeutic purposes; Scientific research services for others in the fields of oncology, immunotherapy treatments, tissue engineering, regenerative medicine and biological cell modification procedures; medical laboratory services; development of cell therapies using genetic cell modification technology; development of gene modified cell therapies; research and development in the pharmaceutical and biotechnology fields; laboratory analysis and industrial research services in the medical, biotechnological, nanomaterials and pharmaceutical fields | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Trince, besloten vennootschap
- Other trademarks owned by Trince, besloten vennootschap
- Other trademarks owned by Trince, besloten vennootschap
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 037
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named TRINCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 9, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 9, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 10, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 10, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 10, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 8, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 8, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 20, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 18, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 4, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 4, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 4, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 3, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 1, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 1, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 1, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 2, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 2, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 21, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 21, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 21, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 21, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 12, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 22, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 22, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 21, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 20, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 14, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 10, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 6, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |